Evidence map›Paper›PMID 42575444›Full record

ArticleThe Journal of biological chemistry2026

Selective recognition of mitochondrial acyl carrier protein by the regulatory protein LYRM2.

Yixing Suo, James J La Clair, Michael D Burkart

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yixing SuoDepartment of Chemistry and Biochemistry, University of California, San Diego, California, USA.
James J La ClairDepartment of Chemistry and Biochemistry, University of California, San Diego, California, USA.
Michael D BurkartDepartment of Chemistry and Biochemistry, University of California, San Diego, California, USA. Electronic address: mburkart@ucsd.edu.

Funding

Human mitochondrial ACP interactionsR21AG073807 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BURKART, MICHAEL D. · 2021 to 2022
$435k
NIA NIH HHS R21 AG073807
6 · The paper itself

Abstract

Human mitochondrial fatty acid synthesis plays a central role in coordinating lipid metabolism with respiratory chain biogenesis through the central mitochondrial acyl carrier protein (mACP). Although several Leucine-Tyrosine-Arginine motif (LYRM) family mitochondrial regulatory proteins have been shown to associate with mACP, the structure or function of most of them has remained undefined. Here, we identify one of the regulatory proteins, LYRM2, as an acyl-chain selective mACP-binding protein. Systematic expression screening of underexplored regulatory proteins revealed LYRM2 as uniquely stable in isolation. Gel electrophoresis analysis demonstrated specific complex formation between LYRM2 and acylated mACP. Biophysical and analytical analyses showed preferential binding to long-chain acyl-mACP species, with strongest interactions observed for C12. These results establish LYRM2 as a selective mACP-interacting protein and support a role for acyl-state recognition in mitochondrial regulatory signaling.

Indexed as

acyl-chain selectivityLYRM proteinmitochondrial acyl carrier proteinmitochondrial fatty acid synthesismitochondrial metabolism

Identifiers

PMID42575444
PMCPMC13579948

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.